| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $94.9M | -0.6% | +17.7% |
| R&D Expense | $19.1M | +15.0% | +32.7% |
| SG&A Expense | $40.1M | -20.4% | -6.9% |
| Operating Income | $21.3M | +47.4% | +111.0% |
| Interest Expense | $1.6M | +0.1% | -3.3% |
| Pre-tax Income | $28.4M | +34.0% | +43.4% |
| Income Tax | $1.5M | -40.2% | -32.9% |
| Net Income | $26.9M | +43.8% | +53.0% |
| EPS (Basic) | $0.23 | +43.8% | +76.9% |
| EPS (Diluted) | $0.21 | +50.0% | +75.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $160.2M | +61.7% | +34.3% |
| Accounts Receivable | $72.4M | +2.3% | -1.3% |
| Inventory | $73.3M | -3.2% | +17.4% |
| Current Assets | $814.3M | +3.6% | -12.1% |
| Total Assets | $946.5M | +3.1% | -10.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $37.6M | — | — |
| Capital Expenditures | $6.6M | — | — |
| Investing Cash Flow | $129.0M | — | — |
| Financing Cash Flow | -$103.9M | — | — |
| Free Cash Flow | $31.0M | — | — |
| $106.8M |
| -9.6% |
| +52.6% |
| Total Liabilities | $412.4M | -2.8% | +8.4% |
| Stockholders' Equity | $534.1M | +8.1% | -21.6% |